Summary
Altria Group, Inc. reported net earnings of $6.9 billion for the fiscal year ending December 31, 2025, a decrease from the prior year. This decline was primarily attributed to a significant gain on the sale of IQOS commercialization rights in the previous year, alongside lower operating income. Despite this, adjusted net earnings saw a modest increase of 2.4% to $9.1 billion, driven by higher operating companies income (OCI) and a lower adjusted tax rate. The company continues its strategic shift "MovingBeyondSmokingTM," focusing on transitioning adult smokers to a smoke-free future and exploring new growth avenues. However, challenges persist, notably the substantial non-cash impairments of $1.16 billion recorded against goodwill and intangible assets within the e-vapor reporting unit due to ongoing regulatory uncertainties and the impact of illicit flavored disposable e-vapor products. The company demonstrated a continued commitment to shareholder returns through dividends and share repurchases, increasing its quarterly dividend rate by 3.9% and maintaining a progressive dividend growth target. While the core smokeable products segment experienced a revenue decline due to lower shipment volumes, pricing actions helped to partially offset this. The oral tobacco products segment showed revenue growth, driven by pricing, though volume/mix declined. The company faces ongoing regulatory scrutiny and market shifts, which it is navigating through its strategic "Optimize & Accelerate" initiative aimed at enhancing efficiency and effectiveness.
Financial Highlights
51 data points| Revenue | $23.28B |
| Cost of Revenue | $5.60B |
| Gross Profit | $14.54B |
| R&D Expenses | $195.00M |
| Operating Income | $9.90B |
| Net Income | $6.95B |
| EPS (Basic) | $4.12 |
| EPS (Diluted) | $4.12 |
| Shares Outstanding (Basic) | 1.68B |
| Shares Outstanding (Diluted) | 1.68B |
Key Highlights
- 1Altria reported net earnings of $6.9 billion for FY2025, down from $11.3 billion in FY2024, largely due to prior-year gains from the IQOS sale.
- 2Adjusted net earnings increased by 2.4% to $9.1 billion, with adjusted diluted EPS growing 4.4% to $5.42, indicating underlying operational improvement.
- 3Significant non-cash impairments totaling $1.16 billion were recorded against the e-vapor reporting unit's goodwill and definite-lived intangible assets, reflecting challenges in the e-vapor market, particularly from illicit products.
- 4The smokeable products segment saw a 3.4% net revenue decline to $20.5 billion, primarily due to a 10.0% decrease in cigarette shipment volume, partially mitigated by pricing increases.
- 5The oral tobacco products segment experienced a slight net revenue increase of 0.9% to $2.8 billion, driven by higher pricing, although shipment volume/mix decreased.
- 6Altria repurchased $1 billion of its stock under its share repurchase program and increased its quarterly dividend by 3.9%, reaffirming its commitment to shareholder returns.
- 7The company's "Optimize & Accelerate" initiative is on track, with ongoing efforts to achieve cumulative savings of at least $600 million by the end of 2029.